The Cell and Gene Therapy Industry Accelerates with New Financing, Partnerships, and Clinical Milestones
The cell and gene therapy (CGT) sector is entering the final quarter of 2025 with remarkable momentum, driven by major financing rounds, strategic partnerships, manufacturing advances, and promising clinical data. Collectively, these developments highlight a sector that continues to mature, moving from scientific promise to commercial and clinical reality. [Read more…]




